In addition, angiogenin delivery significantly increased the life-span and improved motor function in SOD1G93A mice, an established mouse model of ALS when delivered post-symptom onset (Kieran et al., 2008). The gene discussed is ANG; the disease is amyotrophic lateral sclerosis.